| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 18 |
| 1 | LETROZOLE | 17 |
| 2 | RANITIDINE | 17 |
| 3 | LETROZOLE TABLETS | 16 |
| 4 | PACLITAXEL | 16 |
| 5 | BEVACIZUMAB | 15 |
| 6 | NIRAPARIB | 15 |
| 7 | PACLITAXEL (AIBUMIN-BOUND) | 15 |
| 8 | OLAPARIB | 10 |
| 9 | INTERFERON BETA-1A | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLIPUDASE ALFA-RPCP | 1 | 0.0073 |
| 1 | BELINOSTAT | 1 | 0.0028 |
| 2 | NIRAPARIB | 15 | 0.0007 |
| 3 | TOPOTECAN | 4 | 0.0007 |
| 4 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 5 | OLAPARIB | 10 | 0.0005 |
| 6 | TRABECTEDIN | 1 | 0.0004 |
| 7 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | 1 | 0.0004 |
| 8 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 9 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 10 | 0.0005 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 3 | Aromatase Inhibitor [EPC] | 22 | 0.0002 |
| 4 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 17 | 0.0001 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 16 | 0.0001 |